Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00253292 · ClinicalTrials.gov registry record
Psychometric Study of Outcomes Instruments
A clinical trial, sponsored by Massachusetts General Hospital.
- Terminated
- Registry status
- 40
- Enrollment target
NCT00253292: Clinical Trial study, sponsored by Massachusetts General Hospital.
NCT00253292 is a clinical trial that was terminated before completion, run by Massachusetts General Hospital. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00253292 was terminated before completion, sponsored by Massachusetts General Hospital.
- TERMINATED
- Registry status
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a standardized, practical self-administered questionnaire to monitor young adult burn patients and to evaluate the effectiveness of burn management treatments with regard to improved function, physical appearance and other relevant outcomes.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 1997-01 |
| Est. Completion | 2007-12 |
Why NCT00253292 stopped before completion
NCT00253292 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00253292 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00253292 about?
NCT00253292 is a clinical study titled "Psychometric Study of Outcomes Instruments". The purpose of this study is to develop a standardized, practical self-administered questionnaire to monitor young adult burn patients and to evaluate the effectiveness of burn management treatments with regard to improved function, physical appearance and other relevant outcomes.
What is the current status of trial NCT00253292?
This trial is currently terminated. The enrollment target is 40 participants. The study started on 1997-01. Estimated completion is 2007-12.
Who is sponsoring clinical trial NCT00253292?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia